






























We used bevacizumab combined with chemotherapy (carboplatin + paclitaxel therapy) to treat a patient 
with initial-onset stage IVB cervical cancer with major metastases to the para-aortic lymph nodes. This 
treatment resulted in disappearance of the primary lesion and the return of pelvic lymph nodes to normal 
size, while the para- aortic lymph nodes shrank markedly. No subsequent relapse was seen on bevacizumab 
maintenance therapy and no adverse events that would require the cessation of bevacizumab therapy 
occurred.
The present case demonstrates that bevacizumab combined with chemotherapy may offer an effective and 
safe treatment for advanced cervical cancer.
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A case of advanced cervical cancer successfully treated using 
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